Recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 non-nucleoside reverse transcriptase inhibitor binding pocket.
Eur J Med Chem
; 174: 277-291, 2019 Jul 15.
Article
in En
| MEDLINE
| ID: mdl-31051402
Since the entrance channel was proposed as a new binding site in non-nucleoside reverse transcriptase inhibitor binding pocket (NNIBP) of HIV-1 reverse transcriptase (RT) in 2012, a huge number of HIV-1 inhibitors acting on this target have sprung up, aiming to discover promising inhibitors with excellent antiviral activities, physicochemical properties, and so on. From 2012 to 2018, many noteworthy compounds have been continuously discovered. In this review, the recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 NNIBP was summarized and reviewed, which would provide useful clues and inspiration for further design of HIV-1 inhibitors.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV-1
/
Reverse Transcriptase Inhibitors
/
Anti-HIV Agents
/
HIV Reverse Transcriptase
/
Heterocyclic Compounds
Limits:
Animals
/
Humans
Language:
En
Journal:
Eur J Med Chem
Year:
2019
Document type:
Article
Country of publication: